Literature DB >> 21512848

Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Toshifumi Wakai1, Yoshio Shirai, Jun Sakata, Pavel Vladimirovich Korita, Yoichi Ajioka, Katsuyoshi Hatakeyama.   

Abstract

BACKGROUND: The present study investigated outcomes following surgical resection of hepatocellular carcinoma (HCC) in nonalcoholic fatty liver disease (NAFLD).
METHODS: Patients (n = 225) undergoing resection for HCC were divided into three groups: hepatitis C viral group (n = 147), hepatitis B viral group (n = 61), and NAFLD group (n = 17). Clinicopathological characteristics and surgical outcomes were analyzed retrospectively.
RESULTS: Patients in the NAFLD group were older (P < 0.001), with a higher body mass index (P < 0.001) and larger tumors (P = 0.002) than patients who were positive for hepatitis viral markers. Eight patients in the NAFLD group were found to have nonalcoholic steatohepatitis (NASH) histologically. Postoperative morbidity and 30-day mortality rates were significantly higher in the NAFLD group (59% and 12%, respectively) than in the hepatitis C viral (31% and 0.7%, respectively) and hepatitis B viral (28% and 3.3%; P = 0.043 and P = 0.016, respectively) groups. All deaths in the NAFLD group were in patients with NASH-related cirrhosis who had undergone right hemihepatectomy. Survival after resection was comparable among the three groups (P = 0.391), but patients with NAFLD showed better disease-free survival on univariate (P = 0.048) and multivariate (P = 0.020) analyses.
CONCLUSIONS: Surgical resection may provide a survival benefit for patients with NAFLD-related HCC. Patients with NASH-related cirrhosis undergoing major hepatic resection should be treated carefully.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512848     DOI: 10.1007/s11605-011-1540-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  42 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 2.  Strategies for safer liver surgery and partial liver transplantation.

Authors:  Pierre-Alain Clavien; Henrik Petrowsky; Michelle L DeOliveira; Rolf Graf
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

Review 3.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 4.  Nonalcoholic fatty liver disease.

Authors:  F Schaffner; H Thaler
Journal:  Prog Liver Dis       Date:  1986

5.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.

Authors:  N Nagasue; T Ono; A Yamanoi; H Kohno; O N El-Assal; H Taniura; M Uchida
Journal:  Br J Surg       Date:  2001-04       Impact factor: 6.939

6.  [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].

Authors:  Rabia Bencheqroun; Christophe Duvoux; Alain Luciani; Elie-Serge Zafrani; Daniel Dhumeaux
Journal:  Gastroenterol Clin Biol       Date:  2004-05

7.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

8.  Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study.

Authors:  Lucas McCormack; Henrik Petrowsky; Wolfram Jochum; Katarzyna Furrer; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

Review 9.  Hepatocellular carcinoma with nonalcoholic steatohepatitis.

Authors:  Sayaka Mori; Takahiro Yamasaki; Isao Sakaida; Taro Takami; Eiki Sakaguchi; Teruaki Kimura; Fumie Kurokawa; Shiro Maeyama; Kiwamu Okita
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  32 in total

1.  Artificial neural network model for predicting 5-year mortality after surgery for hepatocellular carcinoma: a nationwide study.

Authors:  Hon-Yi Shi; King-Teh Lee; Jhi-Joung Wang; Ding-Ping Sun; Hao-Hsien Lee; Chong-Chi Chiu
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

Review 2.  Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?

Authors:  François Cauchy; David Fuks; Alban Zarzavadjian Le Bian; Jacques Belghiti; Renato Costi
Journal:  World J Hepatol       Date:  2014-05-27

3.  Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk.

Authors:  Alban Zarzavadjian Le Bian; Renato Costi; Vassilis Constantinides; Claude Smadja
Journal:  J Gastrointest Surg       Date:  2012-10-09       Impact factor: 3.452

4.  Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.

Authors:  Yoshihiro Mikuriya; Hirotaka Tashiro; Tsuyoshi Kobayashi; Shintaro Kuroda; Tomoyuki Abe; Masakazu Hashimoto; Hideki Ohdan
Journal:  Langenbecks Arch Surg       Date:  2015-03-06       Impact factor: 3.445

5.  Surgical outcomes in patients with hepatocellular carcinoma associated with metabolic syndrome.

Authors:  Naoki Yoshida; Tadatoshi Takayama; Yutaka Midorikawa; Tokio Higaki; Hisashi Nakayama; Masamichi Moriguchi; Shingo Tsuji
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

Review 6.  Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.

Authors:  Hirotaka Tashiro; Shintaro Kuroda; Yoshihiro Mikuriya; Hideki Ohdan
Journal:  Surg Today       Date:  2014-09       Impact factor: 2.549

7.  Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.

Authors:  Tian Yang; Lun-Yang Hu; Zhen-Li Li; Kai Liu; Han Wu; Hao Xing; Wan Yee Lau; Timothy M Pawlik; Yong-Yi Zeng; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Jun Han; Chao Li; Ming-Da Wang; Meng-Chao Wu; Feng Shen
Journal:  J Gastrointest Surg       Date:  2019-01-07       Impact factor: 3.452

8.  Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Yuki Hirose; Jun Sakata; Takashi Kobayashi; Shun Fujimaki; Masaaki Takamura; Satoshi Yamagiwa; Yutaka Aoyagi
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 9.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

10.  Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.

Authors:  Ping Xu; Cheng-Fu Xu; Xing-Yong Wan; Chao-Hui Yu; Chao Shen; Peng Chen; Gen-Yun Xu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.